| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:42 | Moderna secures $1.5 billion credit facility from Ares Management | ||
| 13:42 | WeShop launches social commerce app allowing users to earn equity | ||
| 13:42 | Leerink Partners upgrades Agios Pharma stock on thalassemia potential | ||
| 13:42 | Citizens maintains Unity Software stock rating at Market Outperform | ||
| 13:42 | BTIG upgrades Avita Medical stock rating to Neutral from Sell | ||
| 13:42 | William Blair upgrades Parsons stock rating to Outperform on growth prospects | ||
| 13:42 | Canaccord Genuity lowers Cybin stock price target to $45 on dilution | ||
| 13:42 | Vericel stock rating reiterated as Neutral by BTIG on MACI Arthro outlook | ||
| 13:42 | Wix.com stock price target lowered to $185 by Citizens on FCF concerns | ||
| 13:42 | Organogenesis stock price target raised to $9 by BTIG on reimbursement changes | ||
| 13:18 | Barclays raises Nvidia stock price target to $275 on strong AI demand | ||
| 13:18 | Needham reiterates Buy rating on Nvidia stock, maintains $240 price target | ||
| 13:18 | Truist Securities raises Nvidia stock price target to $255 on AI growth | ||
| 13:18 | Palo Alto Networks stock rating reiterated at Market Outperform by Citizens | ||
| 13:06 | Viura gas field production stabilizes at 190,000 scm/d in Spain | ||
| 13:06 | Piedmont's tender offer for senior notes sees 46% acceptance rate | ||
| 13:06 | SciSparc subsidiary files patent for depression treatment combination | ||
| 13:06 | Ferguson to issue Q1 results and host conference call on December 9 | ||
| 13:06 | Truist Securities reiterates Buy rating on Palo Alto Networks stock | ||
| 13:06 | Oddity Tech stock rebounds as Citizens reiterates Market Outperform rating | ||
| 13:06 | Jack In The Box stock price target lowered to $16 at Truist Securities | ||
| 13:06 | Oppenheimer maintains Deere stock rating ahead of earnings report | ||
| 13:06 | Citizens reiterates Market Outperform rating on GDS Holdings stock | ||
| 13:06 | William Blair reiterates Outperform rating on Oklo stock after investor lunch | ||
| 13:06 | Nuvation Bio stock price target raised to $10 from $8 at Citizens |